Phase-IIb-Study to Evaluate the Effect of a Neoadjuvant Chemotherapy with Docetaxel, Epirubicine and Cyclphosphamide (TEC) in Patients with primary HER-2 neu Negative Mammacarcinoma.
Phase of Trial: Phase II
Latest Information Update: 30 Aug 2017
At a glance
- Drugs Cyclophosphamide; Docetaxel; Epirubicin
- Indications Breast cancer
- Focus Therapeutic Use
- Acronyms NeoTEC
- 26 Oct 2016 Status changed from active, no longer recruiting to completed.
- 06 Jul 2012 Status changed from recruiting to active, no longer recruiting as reported by German Clinical Trials Register.
- 28 Apr 2012 New source identified and integrated (European Clinical Trials Database; EudraCT2008-003064-19).